Publications by authors named "C Matsushita"
Article Synopsis
- A 71-year-old man with metastatic hormone-sensitive prostate cancer was treated with a combination of medications and palliative radiation therapy targeting specific bones.
- Following the treatment, he developed severe neutropenia on day 35, which halted his treatment and led to a recovery period of 23 days using a granulocyte colony-stimulating factor.
- The case highlights the critical need to prioritize treatment by focusing on specific lesions and to avoid irradiating areas rich in red bone marrow to prevent severe hematological toxicity.
Article Synopsis
- Researchers created a phase-separation multiphase flow in a liquid-liquid interface using polyethylene glycol and phosphate solutions in a microchip and capillary tube setup.
- They observed a unique annular flow where the phosphate-rich phase was in the center and the PEG-rich phase surrounded it, despite the differences in viscosity.
- The study also found that red blood cells concentrated in the inner phosphate-rich phase rather than the outer PEG-rich phase, indicating potential applications for microfluidic flow systems.
Background: To develop a nomogram of urinary volume and flow based on the data of Japanese men without lower urinary tract symptoms and multiple flows per participant whose characteristics were clear.
Methods: Overall, 101 Japanese male volunteers without lower urinary tract symptoms aged between 20 and 59 years were enrolled. A portable uroflowmeter (P-Flowdiary®) was used to record urinary information (flow rate and volume) for 2 successive days.
Identification of diagnostic serum biomarkers for Hunner-type interstitial cystitis.
Low Urin Tract Symptoms
September 2022
Objectives: Diagnosis of Hunner-type interstitial cystitis (HIC) relies on the ability to identify Hunner lesions endoscopically, which can lead to storage symptom misdiagnosis. Here, we examined serum biomarkers for HIC and verified their utility.
Methods: Based on the previous definition of the Japanese guidelines, which did not distinguish HIC and non-HIC diseases, we searched for serum biomarkers in 25 patients with interstitial cystitis (IC) and 25 control participants using metabolomics during 2013-2014.